Egle Therapeutics is based in Paris, France. It has raised $60M in total funding. Latest round: Growth. Backed by EQT Life Sciences, Bpifrance, Fund Plus.
Egle Therapeutics is based in Paris, France. Egle Therapeutics has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Growth announced in March 2025. The round record for Egle Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include EQT Life Sciences, Bpifrance, Fund Plus, Bioqube Factory Fund, Takeda Ventures, JDRF T1D fund. 6 distinct backers are named across the disclosed rounds.
Egle Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Paris below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026